Orthofix Medical Analyst Price Targets

Wall Street analyst price targets and consensus rating for Orthofix Medical (OFIX).

Price Target Range — 11 Quarters

Analyst Consensus — 6 Analysts

4Buy

2Hold

Consensus RatingBuy# Analysts6Avg. Consensus PT$18Upside to Avg. PT+94.4%

Rating Trend — Last 9 Months

Recent Analyst Actions

See all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
Aug 10, 2026	Canaccord Genuity	Caitlin Burrows	PT Cut	Buy	$18→$13
Jul 6, 2026	Barrington Research	Michael Petusky	PT Raise	Outperform	$15→$17
May 22, 2026	Canaccord Genuity	Caitlin Burrows	PT Cut	Buy	$20→$18
May 22, 2026	Barrington Research	Michael Petusky	PT Cut	Outperform	$17→$15
May 22, 2026	Stifel	Thomas Stephan	PT Cut	Buy	$18→$15
Apr 10, 2026	Barrington Research	Michael Petusky	Maintained	Outperform	$17
Mar 9, 2026	Stifel	Thomas Stephan	PT Cut	Buy	$22→$18
Feb 26, 2026	Canaccord Genuity	Caitlin Burrows	PT Cut	Buy	$24→$20
Feb 25, 2026	Barrington Research	Michael Petusky	PT Cut	Outperform	$18→$17
Feb 17, 2026	Barrington Research	Michael Petusky	Maintained	Outperform	$18
Jan 27, 2026	TD Cowen	Mathew Blackman	Initiate	Hold	$14
Nov 5, 2025	Barrington Research	Michael Petusky	PT Raise	Outperform	$17→$18
Oct 28, 2025	Stifel	Thomas Stephan	Reinstates	Buy	$22
Oct 23, 2025	Barrington Research	Michael Petusky	Maintained	Outperform	$17
Sep 23, 2025	Barrington Research	Michael Petusky	Maintained	Outperform	$17
Jun 23, 2025	Barrington Research	Michael Petusky	Initiate	Outperform	$16
Jun 6, 2025	JMP Securities	David Turkaly	Maintained	Market Perform	—
Feb 26, 2025	Canaccord Genuity	Caitlin Burrows	Maintained	Buy	$24
Feb 26, 2025	Roth MKM	Jason Wittes	Maintained	Buy	$22
Jan 22, 2025	Canaccord Genuity	Caitlin Burrows	Initiate	Buy	$24

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
Canaccord Genuity Maintains Buy on Orthofix Medical, Lowers Price Target to $13

Canaccord Genuity analyst Caitlin Burrows maintains Orthofix Medical (NASDAQ:OFIX) with a Buy and lowers the price target from $18 to $13.

Benzinga Newsdesk

PRO
Canaccord Genuity Maintains Buy on Orthofix Medical, Lowers Price Target to $18

Canaccord Genuity analyst Caitlin Burrows maintains Orthofix Medical (NASDAQ:OFIX) with a Buy and lowers the price target from $20 to $18.

Benzinga Newsdesk

Chevron To Rally Around 12%? Here Are 10 Top Analyst Forecasts For Friday

Get the latest analyst rating changes for top companies on Wall Street, including upgrades and downgrades. View complete details at Benzinga.

Avi Kapoor

PRO
Barrington Research Maintains Outperform on Orthofix Medical, Lowers Price Target to $15

Barrington Research analyst Michael Petusky maintains Orthofix Medical (NASDAQ:OFIX) with a Outperform and lowers the price target from $17 to $15.

Benzinga Newsdesk

PRO
Stifel Maintains Buy on Orthofix Medical, Lowers Price Target to $15

Stifel analyst Thomas Stephan maintains Orthofix Medical (NASDAQ:OFIX) with a Buy and lowers the price target from $18 to $15.

Benzinga Newsdesk

A Glimpse Into The Expert Outlook On Orthofix Medical Through 5 Analysts

Benzinga Insights

Orthofix Medical Inc

Orthofix Medical Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRO
Canaccord Genuity Maintains Buy on Orthofix Medical, Lowers Price Target to $13

PRO
Canaccord Genuity Maintains Buy on Orthofix Medical, Lowers Price Target to $18

Chevron To Rally Around 12%? Here Are 10 Top Analyst Forecasts For Friday

PRO
Barrington Research Maintains Outperform on Orthofix Medical, Lowers Price Target to $15

PRO
Stifel Maintains Buy on Orthofix Medical, Lowers Price Target to $15

A Glimpse Into The Expert Outlook On Orthofix Medical Through 5 Analysts

People Also Watch

People Also Watch

Orthofix Medical Inc

Orthofix Medical Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PROCanaccord Genuity Maintains Buy on Orthofix Medical, Lowers Price Target to $13

PROCanaccord Genuity Maintains Buy on Orthofix Medical, Lowers Price Target to $18

Chevron To Rally Around 12%? Here Are 10 Top Analyst Forecasts For Friday

PROBarrington Research Maintains Outperform on Orthofix Medical, Lowers Price Target to $15

PROStifel Maintains Buy on Orthofix Medical, Lowers Price Target to $15

A Glimpse Into The Expert Outlook On Orthofix Medical Through 5 Analysts

People Also Watch

People Also Watch

PRO
Canaccord Genuity Maintains Buy on Orthofix Medical, Lowers Price Target to $13

PRO
Canaccord Genuity Maintains Buy on Orthofix Medical, Lowers Price Target to $18

PRO
Barrington Research Maintains Outperform on Orthofix Medical, Lowers Price Target to $15

PRO
Stifel Maintains Buy on Orthofix Medical, Lowers Price Target to $15